Critical Path Institute (C-Path) and the PKD Foundation hosted a webinar to discuss C-Path’s Translational Therapeutics Accelerator (TRxA) BRIDGe awards, which provide funding for academic researchers developing new therapeutics. The Accelerator’s Executive Director Maaike Everts explained the program’s focus on advancing therapeutics in the areas of brain health, pediatrics, and rare and orphan diseases, with a new dedicated track for polycystic kidney disease (PKD) in collaboration with the PKD Foundation. The webinar detailed the eligibility criteria, funding levels, and the application process for program grants, emphasizing the importance of interdisciplinary teams and clear target product profiles. The session concluded with a Q&A.
Feel free to access the presentation slides here, or recording below.
